Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: To evaluate the effectiveness and safety of a novel hydrophobic aspheric monofocal intraocular lens (IOL) in cataract surgery.
Methods: This is a prospective, multicenter, randomized, open-label, parallel-controlled clinical study, conducted at nine sites in P.R. China. Eligible participants were adults aged 60-80 years with a diagnosis of age-related cataract scheduled for phacoemulsification combined with IOL implantation. Subjects were randomly assigned to receive either the aspheric monofocal IOL (SM60AS, Henan Simedice Biotechnology Co. Ltd., Zhengzhou, China) or the control IOL (SN60WF Alcon Laboratories Inc.). Postoperative outcomes including uncorrected distance visual acuity (UDVA), best-corrected distance visual acuity (CDVA), refractive status, and complications were assessed and compared between the two groups at each follow-up visit.
Results: A total of 173 patients completed the study, including 88 in the SM60AS group and 85 in the SN60WF group. No statistically significant differences were found in CDVA between the two groups at any postoperative visit. Although the SM60AS group showed slightly lower UDVA at day 1, day 7 (p < 0.01) and 12 months (p < 0.05), there were no statistically significant differences in UDVA between the groups at 1, 3, and 6 months. The SM60AS group exhibited a slightly more myopic refractive outcome compared to the control group, while residual astigmatism remained comparable. No serious IOL-related complications were reported in either group.
Conclusion: The novel SM60AS IOL demonstrated satisfactory effectiveness and safety, with clinical outcomes comparable to those of the established control IOL in cataract surgery.
Trial Registration: The trial was officially registered on August 29, 2020, in the Chinese Clinical Trial Registry, with the registration number: ChiCTR2000037527 ( https://www.chictr.org.cn/showproj.html?proj=60164 ).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12269251 | PMC |
| http://dx.doi.org/10.1186/s12886-025-04232-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Visual Outcomes and Patient Satisfaction with Extended Monovision-An Innovative Strategy to Achieve Spectacle Independence in Refractive Lens Exchange.
J Clin Med
August 2025
Department of Ophthalmology, Pallas Kliniken, 4600 Olten, Switzerland.
: Spectacle independence is a key goal in refractive lens exchange (RLE), especially in younger, high-expectation patients. This study evaluates a novel extended monovision approach combining a monofocal aspheric intraocular lens (IOL) in the dominant eye with a rotationally asymmetric bifocal extended-depth-of-focus (EDOF) IOL in the non-dominant eye. The strategy aims to optimize full-range visual performance while minimizing photic phenomena.
View Article and Find Full Text PDFReal-World Visual Outcomes and Rotational Stability of a Monofocal Toric Intraocular Lens.
Clin Ophthalmol
August 2025
Alcon Research, Fort Worth, TX, USA.
Purpose: To assess the real-world distance and intermediate visual outcomes, rotational stability, and adverse events (AEs) of patients implanted with a Clareon aspheric monofocal toric intraocular lens (IOL) preloaded in the AutonoMe delivery system (Alcon, USA; models CNA0T2 to CNA0T6) up to one-month postoperative.
Methods: Surgical charts from January 2021 to October 2023 were reviewed for adult patients (≥18 years) who previously received a CNA0T2 to CNA0T6 (T2 to T6) IOL during uneventful cataract surgery and were targeted for emmetropia/first minus. Overall, charts from 193 eyes of 121 patients were screened, with 161 eyes of 107 patients included in the study.
Comparison of clinical effects of aspherical monofocal and Tecnis ZMB00 multifocal intraocular lenses in patients with age-related cataract.
J Pak Med Assoc
August 2025
Department of Ophthalmology, Harbin 242 Hospital, Harbin, China.
Objective: To compare the clinical effects and outcomes in patients implanted with aspheric monofocal and multifocal intraocular lens.
Methods: This study was conducted from January 2020 to January 2023 at Harbin 242 Hospital in China, using a prospective randomized case-control design. The research subjects were hospitalized patients with age-related cataracts, randomly divided into a control group A receiving single focus intraocular lenses and an intervention group B receiving multi focus intraocular lenses.
Analysis of the Effect of Pupil Size and Corneal Aberration on the Optical Performance of Premium Intraocular Lenses.
J Clin Med
July 2025
Department of Condensed Matter Physics, Faculty of Sciences, University of Cadiz, 11510 Puerto Real, Cádiz, Spain.
: To assess the optical performance of two refractive premium IOLs across pupil sizes and values of corneal spherical aberration (SA). : Two refractive IOLs were evaluated in this study: Tecnis Eyhance and Mini Well. The surface profiles were obtained to calculate the through-object MTF (TO MTF) curves and simulate optotype images.
View Article and Find Full Text PDFPurpose: To evaluate whether differences in asphericity or corneal spherical aberration (SA) affect intraocular lens (IOL) power and visual acuity (VA) among different ethnicities.
Design: Modeling and simulation study based on published clinical data.
Methods: Individual eye models were developed with corneas designed to represent different ethnicities, based on clinical study data, to simulate and determine SA for a 6-mm pupil.